Peculiarities of hemostasis in transurethral resection of prostatic gland using fybrinolysis inhibitor

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Tissue plasminogen activator being the most important component part of fybrinolysis is producing and accumulating in the prostatic gland. In surgical treatment of prostate an increased bleeding often occurs during the surgical operations on the prostate during as well as in post-operative period. General and local fybrino- lysis increase is in case among the reasons of haemor-ragy as a result of mechanical action on prostatic gland tissue in the process of an operation. It is suggested the use of “Tranexam” a tranexamic acid drug to neutralize an increasing fybrinolysis. In 83 patients with benign prostate hyperplasia, which underwent by transurethral resection of prostate, significantly positive effect of Tranexam was found, prescribed in therapeutic doses before operation, during operation and in early postoperative period.

全文:

受限制的访问

作者简介

Evgenii Goloshchapov

Academician I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of the Russian Federation

编辑信件的主要联系方式.
Email: goloshapov@mail.ru
ORCID iD: 0000-0003-4217-2241

Doctor of Medical Science, Professor, Department of Urology

俄罗斯联邦, Saint Petersburg

Georgiy Lukichev

Academician I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of the Russian Federation

Email: goloshapov@mail.ru

MD. Department of Urology

俄罗斯联邦, Saint Petersburg

参考

  1. Камалов А. А., Рядой А. В., Игнашин Н. С. и др. Применение проскара в качестве предоперационной подготовки больных с доброкачественной гиперплазией простаты перед трансуретральной резекцией // Урология. 2002. №5. С. 16–18.
  2. Сергиенко Н. Ф., Романов К. Е., Шаплыгин Л. В. Ошибки, опасности и осложнения при трансуретральной резекции гиперплазии предстательной железы // Урология. 2000. № 6. С. 29–34.
  3. Alvarez J. C., Santiveri F. X., Ramos I. et al. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied // Rev. Esp. Anestesiol. Reanim. 2008. Vol. 55 (2). P. 75–80.
  4. Benoni G., Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: A prospective, randomised, double-blind study of 86 patients // J. Bone Joint Surg. Br. 1996. Vol. 78. P. 434–440.
  5. Benoni G., Fredin H., Knebel R., Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty: A randomized, double-blind study in 40 primary operations // Acta Orthop Scand. 2001. Vol. 72. P. 442–448.
  6. Camarasa M., Ollé G., Serra-Prat M. et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial // Br. J. Anaesth. 2006. Vol. 96(5). P. 576–582.
  7. Ellis M. H., Fredman B., Zohar E. et al. The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement // J. Clin. Anesth. 2001. Vol. 13. P. 509–513.
  8. Engel J. M., Hohaus T., Ruwoldt R., et al. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin // Anesth Analg. 2001. Vol. 92. P. 775–780.
  9. Good L., Peterson E., Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement //Br. J. Anaesth. 2003. Vol. 90. P. 596–599.
  10. Hartung R., Mauermayer W., Beck F., Karcher G. The controlled TUR: a new method for the measurement of intraoperative blood-loss during TUR (author's transl) // Urologe A. 1976. Vol. 15 (5). P. 254–257.
  11. Henry D. A., Carless P. A., Moxey A. J. et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion // Cochrane Database of Systematic Reviews. 2007. Issue 4.
  12. Hiippala S. Т., Strid L., Wennerstrand M. et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty // Br. J. Anaesth.1995. Vol. 74. P. 534–537.
  13. Hiippala S. T., Strid L. J., Wennerstrand M. I. et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty // Anesth. Analg.1997. Vol. 84. P. 839–844.
  14. Jansen A. J., Andreica S., Claeys M. et al. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty // Br. J. Anaesth. 1999. Vol. 83. P. 596–601.
  15. Molloy D. O., Archbold H. A. P., Ogonda L. et al. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement // J. Bone Joint Surg. Br. 2008. Vol. 89-B (3). P. 306–309.
  16. Tanaka N., Sakahashi H., Sato E. et al. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee // J. Bone Joint Surg. Br. 2001. Vol. 83. P. 702–705.
  17. Veien M., Sorensen J. V., Madsen F., Juelsgaard P. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: A randomized, controlled study // Acta Anaesthesiol. Scand. 2002. Vol. 46. P. 1206–1211.
  18. Zohar E., Ellis M., Ifrach N.et al. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement // Anesth. Analg. 2004. Vol. 99. P. 1679–1683.
  19. Zufferey P., Merquiol F., Laporte S. et al. Do Antifibrinolytics Reduce Allogeneic Blood Transfusion in Orthopedic Surgery? // Anesthesiology. 2006. Vol. 105 (5). P. 1034–1046.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Goloshchapov E., Lukichev G., 2021

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ №ФС77-65570 от 04 мая 2016 г.


##common.cookie##